Cargando…

Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients

BACKGROUND: This report describes a real-time PCR (Q-PCR) strategy to quantify Trypanosoma cruzi (T. cruzi) DNA in peripheral blood samples from Chagas disease patients targeted to conserved motifs within the repetitive satellite sequence. METHODOLOGY/PRINCIPAL FINDINGS: The Q-PCR has a detection li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duffy, Tomas, Bisio, Margarita, Altcheh, Jaime, Burgos, Juan Miguel, Diez, Mirta, Levin, Mariano Jorge, Favaloro, Roberto Rene, Freilij, Hector, Schijman, Alejandro Gabriel
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667272/ https://www.ncbi.nlm.nih.gov/pubmed/19381287 http://dx.doi.org/10.1371/journal.pntd.0000419

Ejemplares similares

Longitudinal follow up of serological response in children treated for Chagas disease
por: Moscatelli, Guillermo, et al.
Publicado: (2019)

Prevention of congenital Chagas through treatment of girls and women of childbearing age
por: Moscatelli, Guillermo, et al.
Publicado: (2015)

Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS
por: Bisio, Margarita, et al.
Publicado: (2013)

Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women
por: Carlier, Yves, et al.
Publicado: (2019)

Diagnostic Accuracy of Two Molecular Tools for Diagnosis of Congenital Chagas Disease
por: Bisio, Margarita María Catalina, et al.
Publicado: (2021)

Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
por: Brossas, Jean-Yves, et al.
Publicado: (2021)

Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
por: Moroni, Samanta, et al.
Publicado: (2019)

Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina
por: Moscatelli, Guillermo, et al.
Publicado: (2015)

Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study
por: González, Nicolás Leonel, et al.
Publicado: (2022)

Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults
por: Falk, N., et al.
Publicado: (2022)

Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults
por: Altcheh, Jaime, et al.
Publicado: (2014)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
por: Fernández, Marisa Liliana, et al.
Publicado: (2016)

First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease
por: Ramírez, Juan C., et al.
Publicado: (2017)

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina
por: Niborski, Leticia L, et al.
Publicado: (2016)

Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study
por: Moroni, Samanta, et al.
Publicado: (2016)

Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment
por: Porrás, Analía I., et al.
Publicado: (2015)

Congenital Chagas Disease: Recommendations for Diagnosis, Treatment and Control of Newborns, Siblings and Pregnant Women
por: Carlier, Yves, et al.
Publicado: (2011)

ELISA F29 –A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment
por: Rivero, Rocio, et al.
Publicado: (2023)

Genetic polymorphism of Trypanosoma cruzi bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial
por: Ramírez, Juan Carlos, et al.
Publicado: (2021)

Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease
por: Stass, Heino, et al.
Publicado: (2020)

Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease
por: Parrado, Rudy, et al.
Publicado: (2019)

International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
por: Schijman, Alejandro G., et al.
Publicado: (2011)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation
por: Sartor, Paula, et al.
Publicado: (2017)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2022)

Sensitive and accurate quantification of human malaria parasites using droplet digital PCR (ddPCR)
por: Koepfli, Cristian, et al.
Publicado: (2016)

Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients
por: Melo, Myllena F, et al.
Publicado: (2015)

Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
por: Mucci, Juan, et al.
Publicado: (2017)

Benznidazole Therapy Modulates Interferon-γ and M2 Muscarinic Receptor Autoantibody Responses in Trypanosoma cruzi-Infected Children
por: Cutrullis, Romina A., et al.
Publicado: (2011)

Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole
por: Ruiz-Lancheros, Elizabeth, et al.
Publicado: (2018)

Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory
por: Schijman, Alejandro Gabriel, et al.
Publicado: (2022)

Loop-Mediated Isothermal Amplification of Trypanosoma cruzi DNA for Point-of-Care Follow-Up of Anti-Parasitic Treatment of Chagas Disease
por: Muñoz-Calderón, Arturo A., et al.
Publicado: (2022)

Assessing antibody decline after chemotherapy of early chronic Chagas disease patients
por: Murphy, Niamh, et al.
Publicado: (2021)

Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR
por: D’Ávila, Daniella Alchaar, et al.
Publicado: (2018)

Prospective multicenter evaluation of real time PCR Kit prototype for early diagnosis of congenital Chagas disease
por: Benatar, Alejandro Francisco, et al.
Publicado: (2021)

Neglected Parasitic Infections in the United States: Chagas Disease
por: Montgomery, Susan P., et al.
Publicado: (2014)

An Update on the Knowledge of Parasite–Vector Interactions of Chagas Disease
por: Schaub, Günter A
Publicado: (2021)

Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)
por: Altcheh, Jaime, et al.
Publicado: (2023)

Parasite load evaluation by qPCR and blood culture in Chagas disease and HIV co-infected patients under antiretroviral therapy
por: Marcon, Gláucia Elisete Barbosa, et al.
Publicado: (2022)

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
por: Zingales, Bianca, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_67vhjusab7gt3e83oclm2h2rku